未登录

S

Sui-Qing Cai

zhejiang university school of medicine

H指数:19

被引数:1,175

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Associations of psoriasis history with general discrimination-related experiences in US adults

银屑病病史与美籍成年人一般歧视相关经历的关系

Journal of the European Academy of Dermatology and Venereology

IF8

2026-09-190

PRE

Interleukin-6 as a predictive biomarker of systemic progression and therapeutic target in cutaneous plasmacytosis

白细胞介素-6作为皮肤浆细胞增多症系统性进展的预测生物标志物和治疗靶点

Anais Brasileiros de Dermatologia

IF3.6

2026-03-010

OAAI

Real-world Long-term Drug Survival of Dupilumab in Palmoplantar Pustulosis: A 3-Year Observational Follow-up

真实世界中掌跖脓疱病 Dupilumab 的长期用药维持情况：一项为期 3 年的观察性随访研究

Journal of the American Academy of Dermatology

IF11.8

2025-10-060

PRE

Tattoo-induced hypertrophic discoid lupus erythematosus in apatient with vitiligo

纹身诱发的肥厚性盘状红斑狼疮，发生于一名白癜风患者

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

IF3.8

2025-04-080

PRE

Comments on impact of delay of diagnosis of pyoderma gangrenosum on healing outcomes and health care utilization: A prospective cohort study

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2025-01-010

PRE

Genetic Aspects of Necrobiotic Xanthogranuloma

JAMA DERMATOLOGY

IF11

2024-10-012

PRE

Association Between Atopic Dermatitis and Aging: Clinical Observations and Underlying Mechanisms

inflammation research

IF4.1

2024-05-011

OA

Pseudomyogenic hemangioendothelioma in the external genitalia

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

IF3.8

2024-04-061

PRE

Erythroderma in a Patient With Thymoma-Associated Myasthenia Gravis

JAMA DERMATOLOGY

IF11

2024-02-011

PRE

Efficacy of dupilumab in palmoplantar pustulosis treatment highlights the role of Th2 inflammation

IF12

2024-01-095

PRE

Comparison of 1064-nm Nd:YAG picosecond laser using fractional micro-lens array vs. ablative fractional 2940-nm Er:YAG laser for the treatment of atrophic acne scar in Asians: a 20-week prospective, randomized, split-face, controlled pilot study

FRONTIERS IN MEDICINE

IF3

2023-11-165

OAAI

Case Report: Cadonilimab-related toxic epidermal necrolysis-like reactions successfully treated with supplemental Adalimumab

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-08-035

OAAI

Case Report: Morbihan disease treated with tofacitinib successfully

病例报告: 托法替尼成功治疗Morbihan病

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-06-055

OAAI

Transfer factor for the treatment of necrobiotic xanthogranuloma

DERMATOLOGIC THERAPY

IF3.4

2022-10-181

PRE

Biologics for psoriasis patients under 18 years of age: Real-world evidence from the Chinese psoriasis real world evidence research group

FRONTIERS IN MEDICINE

IF3

2022-09-073

OAAI

Successful treatment of secukinumab-resistant palmoplantar pustulosis by Dupilumab: A case report

DERMATOLOGIC THERAPY

IF3.4

2022-08-304

OA

The treatment of refractory atypical bullous pemphigoid with generalized eczema and intense pruritus with dupilumab

DERMATOLOGIC THERAPY

IF3.4

2021-12-0910

OA

miRNA Profiling of Extracellular Vesicles Reveals Biomarkers for Psoriasis

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2021-01-0116

OAAI

The role of Sprouty1 in the proliferation, differentiation and apoptosis of epidermal keratinocytes

CELL PROLIFERATION

IF5.6

2018-07-2325

OAAI

A missense variant of the ABCC11 gene is associated with Axillary Osmidrosis susceptibility and clinical phenotypes in the Chinese Han Population

SCIENTIFIC REPORTS

IF3.9

2017-05-0911

OAAI